HY-P1026-1mg
|
MedChemexpress LLC
|
NFAT Inhibitor-1 [CAS 249537-73-3]
|
|
COVID-19-immunoregulation
|
|
HY-P1026-10mg
|
MedChemexpress LLC
|
NFAT Inhibitor-1 [CAS 249537-73-3]
|
|
COVID-19-immunoregulation
|
|
HY-P1026-25mg
|
MedChemexpress LLC
|
NFAT Inhibitor-1 [CAS 249537-73-3]
|
|
COVID-19-immunoregulation
|
|
HY-P1026-5mg
|
MedChemexpress LLC
|
NFAT Inhibitor-1 [CAS 249537-73-3]
|
|
COVID-19-immunoregulation
|
|
HY-P2185A-1mg
|
MedChemexpress LLC
|
NFF-3 (TFA)
|
|
|
|
HY-P2185A-10mg
|
MedChemexpress LLC
|
NFF-3 (TFA)
|
|
|
|
HY-P2185A-5mg
|
MedChemexpress LLC
|
NFF-3 (TFA)
|
|
|
|
HY-P2272A-1mg
|
MedChemexpress LLC
|
NLS-StAx-h (TFA)
|
|
|
|
HY-P2272A-100ug
|
MedChemexpress LLC
|
NLS-StAx-h (TFA)
|
|
|
|
HY-P2272A-500ug
|
MedChemexpress LLC
|
NLS-StAx-h (TFA)
|
|
|
|
HY-141449-10mg
|
MedChemexpress LLC
|
NRX-103094 [CAS 2763260-36-0]
|
|
Cancer-programmed cell death
|
|
HY-141449-100mg
|
MedChemexpress LLC
|
NRX-103094 [CAS 2763260-36-0]
|
|
Cancer-programmed cell death
|
|
HY-141449-25mg
|
MedChemexpress LLC
|
NRX-103094 [CAS 2763260-36-0]
|
|
Cancer-programmed cell death
|
|
HY-141449-5mg
|
MedChemexpress LLC
|
NRX-103094 [CAS 2763260-36-0]
|
|
Cancer-programmed cell death
|
|
HY-141449-50mg
|
MedChemexpress LLC
|
NRX-103094 [CAS 2763260-36-0]
|
|
Cancer-programmed cell death
|
|
HY-141450-10mg
|
MedChemexpress LLC
|
NRX-103095 [CAS 2763260-38-2]
|
|
Cancer-programmed cell death
|
|
HY-141450-100mg
|
MedChemexpress LLC
|
NRX-103095 [CAS 2763260-38-2]
|
|
Cancer-programmed cell death
|
|
HY-141450-25mg
|
MedChemexpress LLC
|
NRX-103095 [CAS 2763260-38-2]
|
|
Cancer-programmed cell death
|
|
HY-141450-5mg
|
MedChemexpress LLC
|
NRX-103095 [CAS 2763260-38-2]
|
|
Cancer-programmed cell death
|
|
HY-141450-50mg
|
MedChemexpress LLC
|
NRX-103095 [CAS 2763260-38-2]
|
|
Cancer-programmed cell death
|
|
HY-141450-1mL
|
MedChemexpress LLC
|
NRX-103095 [CAS 2763260-38-2] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-111836-10mg
|
MedChemexpress LLC
|
NRX-252114 [CAS 2763260-39-3]
|
|
Cancer-programmed cell death
|
|
HY-111836-100mg
|
MedChemexpress LLC
|
NRX-252114 [CAS 2763260-39-3]
|
|
Cancer-programmed cell death
|
|
HY-111836-25mg
|
MedChemexpress LLC
|
NRX-252114 [CAS 2763260-39-3]
|
|
Cancer-programmed cell death
|
|
HY-111836-5mg
|
MedChemexpress LLC
|
NRX-252114 [CAS 2763260-39-3]
|
|
Cancer-programmed cell death
|
|